Cholesterol-lowering medication: Impact on the clinical effect of adjuvant endocrine treatment in postmenopausal breast cancer

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKonferenceabstrakt i tidsskriftForskningpeer review

Standard

Cholesterol-lowering medication: Impact on the clinical effect of adjuvant endocrine treatment in postmenopausal breast cancer. / Harborg, Karl Sixten; Heide-Jørgensen, Uffe; Ahern, Thomas; Ewertz, Marianne; Cronin Fenton, Deirdre; Borgquist, Signe.

I: Annals of Oncology, Bind 30, Nr. 3, 13.05.2019, s. iii29-iii30.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKonferenceabstrakt i tidsskriftForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{adb4abd46fbf4c849814ed2d8b2616ad,
title = "Cholesterol-lowering medication: Impact on the clinical effect of adjuvant endocrine treatment in postmenopausal breast cancer",
author = "Harborg, {Karl Sixten} and Uffe Heide-J{\o}rgensen and Thomas Ahern and Marianne Ewertz and {Cronin Fenton}, Deirdre and Signe Borgquist",
year = "2019",
month = may,
day = "13",
doi = "10.1093/annonc/mdz096.008",
language = "English",
volume = "30",
pages = "iii29--iii30",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "3",

}

RIS

TY - ABST

T1 - Cholesterol-lowering medication: Impact on the clinical effect of adjuvant endocrine treatment in postmenopausal breast cancer

AU - Harborg, Karl Sixten

AU - Heide-Jørgensen, Uffe

AU - Ahern, Thomas

AU - Ewertz, Marianne

AU - Cronin Fenton, Deirdre

AU - Borgquist, Signe

PY - 2019/5/13

Y1 - 2019/5/13

U2 - 10.1093/annonc/mdz096.008

DO - 10.1093/annonc/mdz096.008

M3 - Conference abstract in journal

VL - 30

SP - iii29-iii30

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -